Just like any other industry, medical device and pharmaceutical companies are required to follow strict rules and regulations imposed by the government. Unfortunately there will always be rule breakers- intentionally or unintentionally. That’s why a recent article grabbed our attention titled, “The Top 5 Corruption Risks for Pharmaceutical and Medical Device Companies”.

Peter Derycz, CEO of Derycz Scientific published an article in MD+DI that caught our attention.  Derycz indicates that with financial pressures continuing to rise in the medical device industry, one key area that should be looked it is content management.  He indicates that the expenses happen in both the research and marketing phases, and suggest partnering with content technology company is a possible solution.

With the economy the way it is “budget” is a word on everyone’s mind- including those in the medical device industry. It has been discussed that the US might be taking a back seat in the medical technology market because of financing and economic challenges. With these concerns in the back of everyone’s mind a recent article on MD+DI caught my attention. This piece highlights these issues and focuses on cost saving strategies for device startups.

Over the last year, Healing Innovations has stated that they’ve been making a case for great collaboration between the medical device industry and physicians. Interestingly enough, they have also blogged about the “conflict of interest which may result from clinicians becoming mouthpieces for new products and clinical trial results.”